Abstract
Globulin concentrations Specificity of the assay
The specificity of the assay was demonstrated by testing The concentrations of globulin in the serum and in urine were determined by rocket immunoelectrophoresis [10] . To serum with a high concentration of anti-DNA antibodies after incubation with DNA. The concentrations of DNA 10 ml of hot 1% agarose (in barbitone buffer/10 mM EDTA) 75 ml of rabbit polyclonal anti-human IgG serum was added used in the inhibition studies were 0.01-25 mg/tube 60 ml of highly+ve serum diluted 1/100+60 ml of dilutions of DNA and poured on to an 8×8-cm plate. Wells, 2 mm diameter were cut and 4 ml of sample/well was added. The samples were incubated for 30 min+37°C. 100 ml of this solution (final serum dilution 1/200) was added to the wells of DNA were electrophoresed for 12 h at 20 mA/plate. Subsequently the plates were dried and stained. Protein standard serum coated ELISA plates and the standard assay performed.
All anti-DNA positive SLE patients sera were tested (in LC-V (human) Behring (Behring Werke AG, D-35001, Marburg) was used as a standard for human IgG. Samples duplicate) in DNA uncoated plates (blocked with 3% BSA). for IgG determination were mixed with equal volumes of freshly prepared 2 M KCN (at least 50 ml of each) and The effect of inactivation of endogenous urine DNase by reacted at 50°C for 20 min. Final dilutions of sera were EDTA on anti-DNA antibody binding ELISA 15200 and urine, 157.
Plates were coated with calf thymus DNA as described previously. The plates were finally washed in 10 mM
C3 and C4
MOPS/10 mM azide, pH 7.2 (MOPS ). Urine from patients with LN were adjusted to 1 mg/ml BSA and dialysed overThe concentration of serum C3 and C4 was measured by night in MOPS. ELISA plates were prepared in duplicates nephelometry and the CH 50 by functional assay [11] . of 100 ml/well as follows: SLE patients' serum with a high titre of anti-DNA antibodies were diluted in MOPS and added to the urine samples to give a final concentration of
Anti-DNA
1/1000. One set of samples were prepared in MOPS/10 mM EDTA. Solutions were incubated for 60 min and then the Anti-DNA was measured by ELISA. Several methods of anti-DNA ELISA was completed as previously described. coating the ELISA plates with DNA were investigated. In The results (anti-DNA antibody titre) were expressed as preliminary studies, before incubation with DNA, the plates absorbance at 405 and 490 nm, were treated with poly-l-lysine at 10 mg/ml [12] [13] [14] [15] were washed and incubated with the solution of DNA. Calf thymus DNA was dissolved in distilled water to a concentra-To the urine from four LN patients and two healthy laborattion of 5 mg/ml, sonicated 2×2 min at maximum intensity, ory workers (C ), calf thymus DNA was added to a concentradigested with proteinase K, phenol/chloroform extracted ×3 tion of 25 mg/ml with EDTA to 10 mM. The samples were and ethanol precipitated, vacuum dried and finally dissolved incubated for 60 min at room temperature. One hundred in distilled water. The wells of ELISA plates were incubated microlitres of this solution was added to the wells of DNAwith DNA in PBS/1 mM EDTA at concentrations of coated ELISA plates and the standard assay for ELISA anti-2.5-100 mg/ml (100 ml/well ). Preliminary tests were done DNA antibodies was performed. The same urine samples with non-digested DNA or undigested but phenol-were tested for the presence of anti-DNA antibodies without chloroform-extracted DNA. After overnight incubation and pre-incubation with DNA. washing, the plates were blocked with 3% BSA for 30 min at room temperature. The plates were then washed ×3 with Demonstration that the DNA binding activity was of the The urine of four lupus patients and four LN patients were (6-7 months of age) and after the decline of serum antibody tested: 15 ml of urine was concentrated down to 3 ml using titre (9 months of age). Sera were diluted 15200 in washing AMICON B15 concentrators. The pH of the concentrate buffer (urines for urinary anti-DNA were diluted 152) and was adjusted to 5.0 with 3 M acetic acid and 0.5 ml caprylic incubated for 60 min at room temperature. After washing, acid added. The solution was stirred for 30 min at room the plates were incubated with 151000 dilution of peroxidasetemperature then spun at 20 000 r.p.m. for 15 min. The labelled goat anti-mouse IgG (anti-human IgG for human supernatant was removed and precipitated with saturated sera), washed again and then revealed with ABTS in ABTS ammonium sulphate (SAS) at a ratio of 6 ml SAS: 10 ml buffer+H 2 O 2 . The plates were read at dual wave length solution. The solution was then centrifuged for 15 min at measurements, 405 and 490 nm in a plate reader (Bio-Rad).
10 000 r.p.m. and the precipitate collected in 1 ml PBS. The The standard curve was obtained by plotting the ODs of precipate was dialysed against PBS overnight and the protein serial dilutions of 1/100 diluted strongly positive SLE serum.
concentration measured by the method of Lowry et al. [24] . The results were expressed as follows:
The IgG fractions were then tested by the standard antinucUnits equal to 1000×sample absorbance/absorbance of lear antibody test assay (ANF ) and by the anti-DNA ELISA. highly positive human SLE serum.
Statistical analysis
For mice sera (used as standards), the results were expressed as follows:
The differences in the concentrations of IgG and anti-DNA antibodies between normal controls and SLE patients were Units equal to 100×sample absorbance/absorbance obtained with a pool of 9 month old NZB/W F1 hybrid sera.
analysed by Student's t test.
Results

The detection of anti-DNA antibodies
The highest sensitivity and the lowest background were achieved with plates coated only with DNA at a concentration of 5 mg/ml without treatment with methylated BSA, poly-l-lysine, protamine chloride, or protamine sulphate (Figure 1 ). The most effective DNA preparation in the anti-DNA antibody binding tests was proteinase K digested DNA. Twelve twofold dilutions of strongly anti-DNA antibody positive human serum (1/100-1/204 800) were used to plot a standard curve and subsequently calculate the anti-DNA antibody titre in tested human sera. The OD of a positive control standard serum diluted 1/100 was marked as 1000 units.
Serum antibody activity was inhibited by adding free DNA to the test samples. Proteinase K digested All 43 patients included in the study had significant titres (P<0.001) of serum anti-DNA antibodies. In all with proteinuria and especially with urinary IgG excrethe patients total urinary protein, haematuria and tion. One patient with florid SLE was followed therealbuminuria were measured (data not shown). Twenty-after (SM ). In this girl, the initial high concentration four patients presented with proteinuria and globu-of anti-DNA antibodies of 93.329 units dropped to linuria and these patients only had anti-DNA antibod-11.690 units in a period of 2 weeks during which time ies in the urine (Table 1) . Ten patients in this latter she had heavy proteinuria. Later on, proteinuria subgroup had a renal biopsy diagnosis showing renal sided, anuria and renal failure developed and antilesions (2 LN type III and 8 LN type IV by World DNA antibodies disappeared from the circulation. Health Organisation classification criteria) [25] . The Control sera from all 43 patients were tested in results of testing human sera for anti-DNA antibodies plates non-coated with DNA (but blocked with 3% and IgG concentration and human urine for anti-DNA BSA). There was no binding in this assay. antibodies and IgG and the results of the determination of C3, C4 and CH50 in human sera are presented in The effect of inactivation of endogenous urine DNase by Table 1 . Serum anti-DNA antibodies were also meas-EDTA on anti-DNA antibody binding ELISA ured in the 20 SLE patients without LN (data not Urine from 14 SLE patients and six healthy persons shown). However, these patients without proteinuria was tested. To all the urine samples, serum from SLE had no anti-DNA antibodies in their urine. The prespatients with a high titre of anti-DNA antibodies ence of anti-DNA antibodies in urine was correlated (1/1000 final dilution) was added. After incubation in MOPS buffer with or without EDTA, the samples were tested by the ELISA anti-DNA antibody assay ( Figure 3 ). It is evident that both the urine from SLE patients and that from the controls had less anti-DNA antibody when tested in buffer without EDTA. This reduction in antibody binding is due to deoxyribonuclease, i.e. hydrolysis of DNA on the coated plates. Urine from LN patients had more anti-DNA antibody because they contained not only the antibody added from SLE patients' serum but also that from the patients' urine. Some of the LN patients (specially those with high anti-DNA antibody concentration) had no significant reduction in anti-DNA binding in the absence of EDTA. This may be caused by low DNase levels in these LN patients. patients pre-incubated with DNA at the concentration Values greater than 1 for excretion and less than −1 for retention are bold. The patients are ranked in the order of the difference.
Specificity of the ELISA anti-DNA antibody assay for measuring urine anti-DNA antibodies
Complement: Low, C3, C4 or CH50 less than normal mean-2 SD; Normal, within normal range; n.a., not available.
Renal biopsy: 3, focal proliferative glomerulonephritis; 4, diffuse proliferative lupus nephritis; n.a., not available. of 25 mg/ml was significantly reduced. Analogous test (ANF ) and by the anti-DNA ELISA ( Table 2 ).
All the samples had a high anti-DNA antibody titre experiments were done with the serum of SLE patients and a similar reduction of anti-DNA activity was in the anti-DNA ELISA and two of the samples were also positive in the ANF test. demonstrated ( Figure 4) .
Demonstration that the DNA binding activity was of the Discussion molecular weight expected for IgG
IgG, fractionated from the urine of four patients with The modified and specific ELISA was used to detect LN, was tested by the standard anti-nuclear antibody anti-DNA antibodies not only in the sera, but also in the urine of a number of LN patients (type III and IV, in biopsied patients). To avoid the interference of DNase, EDTA was used in all the buffers ( EDTA chelates Mg2+ and Ca2+ which are required for DNase activity). Both serum and urine contain free DNase that may degrade the DNA which is used as an antigen in both ELISA and Farr tests. The presence of DNase in the urine [8] is probably the major reason for the previously reported failure to detect anti-DNA antibodies in the urine of SLE patients or lupus mice. EDTA was not apparently used in the tests reported [5] [6] [7] . A decrease in serum anti-DNA antibody titre coin- cident with the development of nephrotic syndrome gested that there was no extensive breakdown of the trapped immune complexes. has been observed in some SLE patients [5, 7, 26 ] . However, the reports on the presence of anti-DNA
